Anxiety and Depression May Explain How Social Support Shapes Quality of Life in Glaucoma Patients

Glaucoma has long been understood as a disease of the optic nerve, a condition that quietly steals peripheral vision and, if left untreated, can lead to irreversible blindness. But a new study from researchers in Shanghai suggests that the true burden of the disease extends far beyond the visual field, reaching into the emotional lives of patients and shaping how they experience the world. The research, published in BMC Psychology, finds that psychological distress — a combined measure of anxiety and depression symptoms — may be the critical missing link that explains how social support influences vision-related quality of life in people with primary open-angle glaucoma.

Primary open-angle glaucoma, or POAG, is the most common form of glaucoma worldwide and a leading cause of permanent vision loss. Because it progresses slowly and often without symptoms in its early stages, many patients live with the disease for decades, managing daily eye drops, attending regular monitoring appointments, and coping with the knowledge that any vision they lose will never come back. This chronic, unpredictable nature makes glaucoma not just an ophthalmological problem but a psychological one, and it is precisely this intersection that the new study set out to explore.

The research team, led by Yihong Zhu, Wanting Shu, Jiamin Xie and Xueli Chen of Shanghai General Hospital and Shanghai Jiao Tong University School of Medicine, together with biostatistician Wei Zhang of Fudan University, recruited 124 outpatients diagnosed with primary open-angle glaucoma. Between August 2024 and January 2025, each participant completed a battery of standardized questionnaires designed to capture three distinct dimensions of their experience: how their vision affects daily life, how much social support they perceive, and how much psychological distress they carry.

To measure vision-related quality of life, the researchers used the 25-Item National Eye Institute Visual Function Questionnaire, widely regarded as the gold standard for assessing how eye disease affects activities such as reading, driving, and navigating one’s surroundings. Social support was assessed with the Social Support Rating Scale, which gauges the degree of emotional, practical, and informational backing a patient receives from family, friends, and community. Psychological distress was captured with the four-item Patient Health Questionnaire, a compact screening tool that combines symptoms of depression and anxiety into a single score. Socio-demographic details, including education, income, smoking history, and the presence of other chronic illnesses, were collected at the same time.

The initial, univariate analyses painted a familiar but sobering picture. Patients with lower educational attainment reported poorer vision-related quality of life, as did those who felt a heavier economic burden from their glaucoma treatment, those living with chronic comorbid conditions, and those who formerly or currently smoked. Each of these factors was statistically associated with worse self-reported functioning and well-being, with the strongest signals coming from education and financial strain, both at P values below 0.001.

But the more revealing findings emerged when the researchers moved to multiple regression analysis, a statistical technique that allows scientists to determine which factors retain their explanatory power once the overlapping effects of the others are accounted for. When the psychological distress score was added to the model, the picture shifted dramatically. Psychological distress, economic burden, and smoking remained significant predictors of quality of life. The associations for social support and education, however, were attenuated — weakened to the point of losing statistical significance. In other words, much of what had appeared to be a direct benefit of social support seemed to operate through a psychological channel.

To test this possibility formally, the team conducted a mediation analysis, a method that decomposes the relationship between two variables into a direct effect and an indirect effect that passes through a third variable. The results were striking. The indirect effect of social support on vision-related quality of life, transmitted through psychological distress, was statistically significant, with a path coefficient of 0.185 and a P value below 0.001. The direct effect — the portion of the relationship not explained by distress — was not statistically significant, with a coefficient of 0.312 and a P value of 0.081. Taken together, these numbers suggest that psychological distress may account for a substantial portion of the observed association between social support and how glaucoma patients experience their vision in daily life.

The interpretation, the authors caution, is correlational rather than causal. Because the study is cross-sectional — a snapshot of a single moment in time — it cannot establish whether low social support causes psychological distress, whether distress causes patients to perceive less support, or whether both are shaped by some other factor such as disease severity. The researchers are explicit on this point, noting that longitudinal studies are needed to confirm the directionality of the relationships they observed. Still, the pattern they uncovered is consistent with a plausible biological and psychological mechanism: social connections may buffer the emotional toll of living with a progressive, sight-threatening disease, and it is this buffering — rather than any direct practical assistance — that preserves quality of life.

The clinical implications could be significant. If psychological distress is indeed the pathway through which social support exerts its influence, then screening for anxiety and depression could become as routine in glaucoma clinics as measuring intraocular pressure. The authors suggest that integrating psychological distress screening into standard glaucoma care may hold real value, allowing ophthalmologists to identify patients who are struggling emotionally and to connect them with mental health resources before distress compounds the burden of vision loss. Such an approach would represent a shift toward truly holistic care for a disease that has traditionally been managed almost exclusively through pressure-lowering drops, laser treatment, and surgery.

The study also carries a broader message about how medicine measures success. For a patient with glaucoma, a stable visual field on paper does not necessarily mean a good life. The findings underscore that quality of life in chronic eye disease is woven from social, economic, and psychological threads as much as from clinical ones, and that interventions aimed at strengthening social support may pay dividends precisely because they ease the anxiety and depression that so often accompany progressive vision loss. As the global population ages and the number of people living with glaucoma continues to climb, research like this reminds clinicians and researchers alike that the goal of treatment is not merely to preserve sight, but to preserve the person behind the eyes.

Subject of Research: Psychological distress as a mediator between social support and vision-related quality of life in primary open-angle glaucoma

Article Title: Beyond vision loss: psychological distress as a potential pathway linking social support to vision-related quality of life in glaucoma

Article References: Zhu, Y., Shu, W., Xie, J., Zhang, W., & Chen, X. (2026). Beyond vision loss: psychological distress as a potential pathway linking social support to vision-related quality of life in glaucoma. BMC Psychology. https://doi.org/10.1186/s40359-026-05737-2

Image Credits: AI Generated

DOI: 10.1186/s40359-026-05737-2

Keywords: glaucoma, primary open-angle glaucoma, psychological distress, social support, quality of life, vision-related quality of life, mediation analysis, anxiety, depression, NEI-VFQ-25, mental health screening, ophthalmology